SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Genomic screening for blood-borne viruses in transfusion settings
4 references·5 citing·32 second hop
Genomic screening for blood-borne viruses in transfusion settings (2000)Genomic screening for blood-borne viruses…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Feasibility and efficacy of r…Mini‐pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results (1998)Mini‐pool screening by nuclei…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests (1995)Post-transfusion hepatitis: i…Prevalence of HIV among blood donors in a tertiary care centre of north India (2011)Prevalence of HIV among blood…Improving blood donor screening by nucleic acid technology (NAT) (2010)Improving blood donor screeni…Surveillance of risk profiles among new and repeat blood donors with transfusion‐transmissible infections from 1995 through 2003 in the Netherlands (2006)Surveillance of risk profiles…Prevention of transfusion‐transmitted hepatitis E by donor‐initiated self exclusion (2005)Prevention of transfusion‐tra…[Risk of transfusional-transmitted infections]. (2002)[Risk of transfusional-transm…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Impact of grey zone sample testing by enzyme-linked immunosorbent assay in enhancing blood safety: Experience at a tertiary care hospital in North India (2015)Assessing risks of infection with herpes viruses during transfusion of donor blood and its components (2020)Calculation of Polychotomous Logistic Regression Parameters Using Individualized Regressions (1984)Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood (1986)The Risk of Transfusion-Transmitted Infection (1992)Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT (2002)Emerging Infectious Threats to the Blood Supply (2004)A Framework for Applying the Precautionary Principle to Transfusion Safety (2011)Trends of HIV infection in the blood donors of Delhi. (1996)Prevalence of HIV and VDRL seropositivity in blood donors of Delhi. (2005)Infectious Disease Markers in Blood Donors (2008)Transfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India (2014)Blood Donor notification and counseling of reactive test result in Blood Bank of South Gujarat: A better approach to prevent reactive donors from donating blood again (2016)Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India (2016)Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study (1995)The Impact of Emerging Infectious Diseases on Chinese Blood Safety (2016)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Knowledge, Attitudes and Motivations Among Blood Donors in São Paulo, Brazil (2008)Motivation and social capital among prospective blood donors in three large blood centers in Brazil (2012)Sexual risk behaviour and donor deferral in Europe (2014)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Reducing the risk of infection from plasma products: specific preventative strategies (2000)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Nucleic acid amplification technology methods used in blood donor screening (2002)Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? (2008)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)The value of increased neopterin levels in reducing transfusion-transmitted virus infections: detection of a donation from a HBsAg positive chronic carrier by screening of neopterin in Turkish blood donors (2005)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 1999Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting254 cited
  • 1995Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests91 cited
  • 1998Mini‐pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results74 cited

Cited by

  • 2006Surveillance of risk profiles among new and repeat blood donors with transfusion‐transmissible infections from 1995 through 2003 in the Netherlands52 cited
  • 2011Prevalence of HIV among blood donors in a tertiary care centre of north India34 cited
  • 2005Prevention of transfusion‐transmitted hepatitis E by donor‐initiated self exclusion21 cited
  • 2002[Risk of transfusional-transmitted infections].13 cited
  • 2010Improving blood donor screening by nucleic acid technology (NAT)12 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work